Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Non Small Cell Lung Cancer × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 33 Esophageal Squamous Cell Carcinoma 19 Carcinoma, Non-Small-Cell Lung 19 Carcinoma, Hepatocellular 18 Squamous Cell Carcinoma of Head and Neck 15 Triple Negative Breast Neoplasms 14 Breast Neoplasms 12 Uterine Cervical Neoplasms 11 Small Cell Lung Carcinoma 10 Melanoma 10 Colorectal Neoplasms 10 Stomach Neoplasms 8 Recurrence 8 Carcinoma, Renal Cell 8 Head and Neck Neoplasms 6 Rectal Neoplasms 5 Neoplasm Metastasis 5 Esophageal Neoplasms 5 Carcinoma, Transitional Cell 5 Advanced Solid Tumor 5 Sarcoma 4 Pancreatic Neoplasms 4 Neoplasms 4 Liver Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Cholangiocarcinoma 4 Urinary Bladder Neoplasms 3 Solid Tumor 3 Lung Neoplasms 3

Interventions

toripalimab 1 sintilimab 1 pemigatinib 1 Vinorelbine 1 Platinum Compounds 1 Nivolumab 1 Ipilimumab 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04144608 2024-08-09

TOGATHER

Hunan Province Tumor Hospital

Phase 2 Completed

Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡